Stay updated on Immunotherapy with Chemo in HER2-neg IBC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy with Chemo in HER2-neg IBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy with Chemo in HER2-neg IBC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    UI/navigation updates were applied: new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. Additionally, the Intervention/Treatment heading was standardized and the older Intervention / Treatment heading and the Revision: v3.5.5 tag were removed.
    Difference
    0.3%
    Check dated 2026-06-12T13:39:28.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, indicating a small CMS/content update.
    Difference
    0.0%
    Check dated 2026-06-05T08:40:32.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4 indicates a new build of the site; this is an administrative change and does not alter the study content.
    Difference
    0.0%
    Check dated 2026-05-15T05:34:46.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page’s displayed software/version revision label was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:41:17.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:56:12.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    - Added a new reference term 'Inflammatory breast carcinoma' and a Resources entry for the Genetic and Rare Diseases Information Center. - Added iRECIST guideline citation (Lancet Oncol. 2017) to the study references and removed the corresponding Erratum (Lancet Oncol. 2019).
    Difference
    0.2%
    Check dated 2026-04-02T15:47:54.000Z thumbnail image

Stay in the know with updates to Immunotherapy with Chemo in HER2-neg IBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy with Chemo in HER2-neg IBC Clinical Trial page.